207 related articles for article (PubMed ID: 31133456)
1. The C3a/C3aR axis mediates anti-inflammatory activity and protects against uropathogenic E coli-induced kidney injury in mice.
Wu KY; Zhang T; Zhao GX; Ma N; Zhao SJ; Wang N; Wang JX; Li ZF; Zhou W; Li K
Kidney Int; 2019 Sep; 96(3):612-627. PubMed ID: 31133456
[TBL] [Abstract][Full Text] [Related]
2. Targeting C3a/C5a receptors inhibits human mesangial cell proliferation and alleviates immunoglobulin A nephropathy in mice.
Zhang Y; Yan X; Zhao T; Xu Q; Peng Q; Hu R; Quan S; Zhou Y; Xing G
Clin Exp Immunol; 2017 Jul; 189(1):60-70. PubMed ID: 28295247
[TBL] [Abstract][Full Text] [Related]
3. C3a, C5a renal expression and their receptors are correlated to severity of IgA nephropathy.
Liu L; Zhang Y; Duan X; Peng Q; Liu Q; Zhou Y; Quan S; Xing G
J Clin Immunol; 2014 Feb; 34(2):224-32. PubMed ID: 24327134
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Complement C3a and C5a receptors Does Not Prevent Angiotensin II-Induced Hypertension and Hypertensive End-Organ Damage.
Bode M; Herrnstadt GR; Dreher L; Ehnert N; Kirkerup P; Lindenmeyer MT; Meyer-Schwesinger CF; Ehmke H; Köhl J; Huber TB; Krebs CF; Steinmetz OM; Wiech T; Wenzel UO
Hypertension; 2024 Jan; 81(1):138-150. PubMed ID: 37909169
[TBL] [Abstract][Full Text] [Related]
5. C3a and C5a promote renal ischemia-reperfusion injury.
Peng Q; Li K; Smyth LA; Xing G; Wang N; Meader L; Lu B; Sacks SH; Zhou W
J Am Soc Nephrol; 2012 Sep; 23(9):1474-85. PubMed ID: 22797180
[TBL] [Abstract][Full Text] [Related]
6. The Complement C3a
Ren W; Liu Y; Wang X; Piao C; Ma Y; Qiu S; Jia L; Chen B; Wang Y; Jiang W; Zheng S; Liu C; Dai N; Lan F; Zhang H; Song WC; Du J
J Immunol; 2018 Mar; 200(5):1829-1838. PubMed ID: 29367209
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles of the anaphylatoxins C3a and C5a in dendritic cell-mediated allergic asthma.
Engelke C; Wiese AV; Schmudde I; Ender F; Ströver HA; Vollbrandt T; König P; Laumonnier Y; Köhl J
J Immunol; 2014 Dec; 193(11):5387-401. PubMed ID: 25355927
[TBL] [Abstract][Full Text] [Related]
8. Protective role for C3aR in experimental chronic pyelonephritis.
Zhao SJ; Wu KY; Min XY; Wang CX; Cao B; Ma N; Yang XL; Zhu ZR; Fu RG; Zhou W; Yang JR; Li K
FASEB J; 2022 Nov; 36(11):e22599. PubMed ID: 36250902
[TBL] [Abstract][Full Text] [Related]
9. Mast cell anaphylatoxin receptor expression can enhance IgE-dependent skin inflammation in mice.
Schäfer B; Piliponsky AM; Oka T; Song CH; Gerard NP; Gerard C; Tsai M; Kalesnikoff J; Galli SJ
J Allergy Clin Immunol; 2013 Feb; 131(2):541-8.e1-9. PubMed ID: 22728083
[TBL] [Abstract][Full Text] [Related]
10. The receptor for complement component C3a mediates protection from intestinal ischemia-reperfusion injuries by inhibiting neutrophil mobilization.
Wu MC; Brennan FH; Lynch JP; Mantovani S; Phipps S; Wetsel RA; Ruitenberg MJ; Taylor SM; Woodruff TM
Proc Natl Acad Sci U S A; 2013 Jun; 110(23):9439-44. PubMed ID: 23696668
[TBL] [Abstract][Full Text] [Related]
11. Contribution of the anaphylatoxin receptors, C3aR and C5aR, to the pathogenesis of pulmonary fibrosis.
Gu H; Fisher AJ; Mickler EA; Duerson F; Cummings OW; Peters-Golden M; Twigg HL; Woodruff TM; Wilkes DS; Vittal R
FASEB J; 2016 Jun; 30(6):2336-50. PubMed ID: 26956419
[TBL] [Abstract][Full Text] [Related]
12. Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models.
Ames RS; Lee D; Foley JJ; Jurewicz AJ; Tornetta MA; Bautsch W; Settmacher B; Klos A; Erhard KF; Cousins RD; Sulpizio AC; Hieble JP; McCafferty G; Ward KW; Adams JL; Bondinell WE; Underwood DC; Osborn RR; Badger AM; Sarau HM
J Immunol; 2001 May; 166(10):6341-8. PubMed ID: 11342658
[TBL] [Abstract][Full Text] [Related]
13. Deletion of both the C3a and C5a receptors fails to protect against experimental autoimmune encephalomyelitis.
Ramos TN; Wohler JE; Barnum SR
Neurosci Lett; 2009 Dec; 467(3):234-6. PubMed ID: 19850104
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Anaphylatoxin Receptor Expression and C3a/C5a Functions in Anaphylatoxin Receptor Reporter Mice.
Laumonnier Y; Karsten CM; Köhl G; Köhl J
Curr Protoc Immunol; 2020 Sep; 130(1):e100. PubMed ID: 32710701
[TBL] [Abstract][Full Text] [Related]
15. C3a and C5a receptor antagonists ameliorate endothelial-myofibroblast transition via the Wnt/β-catenin signaling pathway in diabetic kidney disease.
Li L; Chen L; Zang J; Tang X; Liu Y; Zhang J; Bai L; Yin Q; Lu Y; Cheng J; Fu P; Liu F
Metabolism; 2015 May; 64(5):597-610. PubMed ID: 25682062
[TBL] [Abstract][Full Text] [Related]
16. Expression of the complement anaphylatoxin C3a and C5a receptors on bronchial epithelial and smooth muscle cells in models of sepsis and asthma.
Drouin SM; Kildsgaard J; Haviland J; Zabner J; Jia HP; McCray PB; Tack BF; Wetsel RA
J Immunol; 2001 Feb; 166(3):2025-32. PubMed ID: 11160252
[TBL] [Abstract][Full Text] [Related]
17. The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.
Mueller-Ortiz SL; Morales JE; Wetsel RA
J Immunol; 2014 Aug; 193(3):1278-89. PubMed ID: 24981453
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of pulmonary Th17 responses by C3a anaphylatoxin during allergic inflammation in mice.
Lim H; Kim YU; Drouin SM; Mueller-Ortiz S; Yun K; Morschl E; Wetsel RA; Chung Y
PLoS One; 2012; 7(12):e52666. PubMed ID: 23285141
[TBL] [Abstract][Full Text] [Related]
19. Activation of endogenous anti-inflammatory mediator cyclic AMP attenuates acute pyelonephritis in mice induced by uropathogenic Escherichia coli.
Wei Y; Li K; Wang N; Cai GD; Zhang T; Lin Y; Gui BS; Liu EQ; Li ZF; Zhou W
Am J Pathol; 2015 Feb; 185(2):472-84. PubMed ID: 25478807
[TBL] [Abstract][Full Text] [Related]
20. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor.
Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE
J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
